194 related articles for article (PubMed ID: 30341459)
1. The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomes.
Blough BE; Decker AM; Landavazo A; Namjoshi OA; Partilla JS; Baumann MH; Rothman RB
Psychopharmacology (Berl); 2019 Mar; 236(3):915-924. PubMed ID: 30341459
[TBL] [Abstract][Full Text] [Related]
2. Systematic Structure-Activity Studies on Selected 2-, 3-, and 4-Monosubstituted Synthetic Methcathinone Analogs as Monoamine Transporter Releasing Agents.
Walther D; Shalabi AR; Baumann MH; Glennon RA
ACS Chem Neurosci; 2019 Jan; 10(1):740-745. PubMed ID: 30354055
[TBL] [Abstract][Full Text] [Related]
3. Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin.
Suyama JA; Sakloth F; Kolanos R; Glennon RA; Lazenka MF; Negus SS; Banks ML
J Pharmacol Exp Ther; 2016 Jan; 356(1):182-90. PubMed ID: 26645638
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs.
Cozzi NV; Brandt SD; Daley PF; Partilla JS; Rothman RB; Tulzer A; Sitte HH; Baumann MH
Eur J Pharmacol; 2013 Jan; 699(1-3):180-7. PubMed ID: 23178523
[TBL] [Abstract][Full Text] [Related]
5. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
[TBL] [Abstract][Full Text] [Related]
6. Structure-Activity Relationships of Synthetic Cathinones.
Glennon RA; Dukat M
Curr Top Behav Neurosci; 2017; 32():19-47. PubMed ID: 27830576
[TBL] [Abstract][Full Text] [Related]
7. Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain.
Bennett BA; Wichems CH; Hollingsworth CK; Davies HM; Thornley C; Sexton T; Childers SR
J Pharmacol Exp Ther; 1995 Mar; 272(3):1176-86. PubMed ID: 7891330
[TBL] [Abstract][Full Text] [Related]
8. Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.
Blough BE; Landavazo A; Decker AM; Partilla JS; Baumann MH; Rothman RB
Psychopharmacology (Berl); 2014 Oct; 231(21):4135-44. PubMed ID: 24800892
[TBL] [Abstract][Full Text] [Related]
9. Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.
Negus SS; Banks ML
Curr Top Behav Neurosci; 2017; 32():119-131. PubMed ID: 27696217
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.
Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Swanson TL; Nilsen A; Janowsky A
Psychopharmacology (Berl); 2019 Mar; 236(3):939-952. PubMed ID: 30397775
[TBL] [Abstract][Full Text] [Related]
11. Methcathinone and 3-Fluoromethcathinone Stimulate Spontaneous Horizontal Locomotor Activity in Mice and Elevate Extracellular Dopamine and Serotonin Levels in the Mouse Striatum.
Wojcieszak J; Andrzejczak D; Wojtas A; Gołembiowska K; Zawilska JB
Neurotox Res; 2019 Apr; 35(3):594-605. PubMed ID: 30377956
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships at monoamine transporters and muscarinic receptors for N-substituted-3alpha-(3'-chloro-, 4'-chloro-, and 4',4''-dichloro-substituted-diphenyl)methoxytropanes.
Newman AH; Robarge MJ; Howard IM; Wittkopp SL; George C; Kopajtic T; Izenwasser S; Katz JL
J Med Chem; 2001 Feb; 44(4):633-40. PubMed ID: 11170654
[TBL] [Abstract][Full Text] [Related]
14. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
[TBL] [Abstract][Full Text] [Related]
15. Methcathinone decreases dopamine transporter function: Role of protein kinase C.
Magee CP; Le BD; Siripathane YH; Wilkins DG; Hanson GR; Fleckenstein AE
J Neurochem; 2021 Oct; 159(1):116-127. PubMed ID: 34320222
[TBL] [Abstract][Full Text] [Related]
16. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors.
Tamiz AP; Zhang J; Flippen-Anderson JL; Zhang M; Johnson KM; Deschaux O; Tella S; Kozikowski AP
J Med Chem; 2000 Mar; 43(6):1215-22. PubMed ID: 10737754
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological properties of new 2beta-alkyl- and 2beta-aryl-3-(substituted phenyl)tropane derivatives: stereochemical effect of C-3 on affinity and selectivity for neuronal dopamine and serotonin transporters.
Kozikowski AP; Araldi GL; Prakash KR; Zhang M; Johnson KM
J Med Chem; 1998 Dec; 41(25):4973-82. PubMed ID: 9836615
[TBL] [Abstract][Full Text] [Related]
18. Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues.
Bonano JS; Banks ML; Kolanos R; Sakloth F; Barnier ML; Glennon RA; Cozzi NV; Partilla JS; Baumann MH; Negus SS
Br J Pharmacol; 2015 May; 172(10):2433-44. PubMed ID: 25438806
[TBL] [Abstract][Full Text] [Related]
19. Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.
Hoepping A; Johnson KM; George C; Flippen-Anderson J; Kozikowski AP
J Med Chem; 2000 May; 43(10):2064-71. PubMed ID: 10821718
[TBL] [Abstract][Full Text] [Related]
20. Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships.
Maryanoff BE; McComsey DF; Gardocki JF; Shank RP; Costanzo MJ; Nortey SO; Schneider CR; Setler PE
J Med Chem; 1987 Aug; 30(8):1433-54. PubMed ID: 3039136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
